Prepaid Expenses (Details) - USD ($) $ in Thousands |
Sep. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
| Non-clinical research and clinical development services | $ 13,517 | $ 17,362 |
| Supply and manufacturing services | 9,961 | 3,494 |
| Insurances | 799 | 886 |
| Other prepayments | 1,656 | 1,115 |
| Total | $ 25,933 | $ 22,857 |
| X | ||||||||||
- Definition Prepaid Research And Development Expense No definition available.
|
| X | ||||||||||
- Definition Supply And Manufacturing Expense, Current No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|